261 related articles for article (PubMed ID: 25193665)
1. Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.
Chao KL; Gorlatova NV; Eisenstein E; Herzberg O
J Biol Chem; 2014 Oct; 289(43):29948-60. PubMed ID: 25193665
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the Sema-PSI extracellular domain of human RON receptor tyrosine kinase.
Chao KL; Tsai IW; Chen C; Herzberg O
PLoS One; 2012; 7(7):e41912. PubMed ID: 22848655
[TBL] [Abstract][Full Text] [Related]
3. The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation.
Angeloni D; Danilkovitch-Miagkova A; Miagkov A; Leonard EJ; Lerman MI
J Biol Chem; 2004 Jan; 279(5):3726-32. PubMed ID: 14597639
[TBL] [Abstract][Full Text] [Related]
4. Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/β-catenin pathway activation in a mouse model.
Lu T; Wang Z; Prativa S; Xu Y; Wang T; Zhang Y; Yu L; Xu N; Tang J; You W; Chen G; Zhang JH
J Neurochem; 2019 Jan; 148(1):114-126. PubMed ID: 30380151
[TBL] [Abstract][Full Text] [Related]
5. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
Thangasamy A; Rogge J; Ammanamanchi S
J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.
Kauder SE; Santell L; Mai E; Wright LY; Luis E; N'Diaye EN; Lutman J; Ratti N; Sa SM; Maun HR; Stefanich E; Gonzalez LC; Graham RR; Diehl L; Faubion WA; Keir ME; Young J; Chaudhuri A; Lazarus RA; Egen JG
PLoS One; 2013; 8(12):e83958. PubMed ID: 24409221
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities.
Wang MH; Zhou YQ; Chen YQ
Scand J Immunol; 2002 Dec; 56(6):545-53. PubMed ID: 12472665
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.
Morrison AC; Wilson CB; Ray M; Correll PH
J Immunol; 2004 Feb; 172(3):1825-32. PubMed ID: 14734766
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
Wang MH; Wang D; Chen YQ
Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
[TBL] [Abstract][Full Text] [Related]
10. Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitution.
Gorlatova N; Chao K; Pal LR; Araj RH; Galkin A; Turko I; Moult J; Herzberg O
PLoS One; 2011; 6(11):e27269. PubMed ID: 22087277
[TBL] [Abstract][Full Text] [Related]
11. The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.
Millar R; Kilbey A; Remak SJ; Severson TM; Dhayade S; Sandilands E; Foster K; Bryant DM; Blyth K; Coffelt SB
Mol Oncol; 2020 Aug; 14(8):1868-1880. PubMed ID: 32484599
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.
Ma Q; Zhang K; Yao HP; Zhou YQ; Padhye S; Wang MH
Int J Oncol; 2010 Jun; 36(6):1551-61. PubMed ID: 20428780
[TBL] [Abstract][Full Text] [Related]
13. MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.
Huang L; Fang X; Shi D; Yao S; Wu W; Fang Q; Yao H
Front Immunol; 2020; 11():569082. PubMed ID: 33117355
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the beta-chain of human hepatocyte growth factor-like/macrophage stimulating protein.
Carafoli F; Chirgadze DY; Blundell TL; Gherardi E
FEBS J; 2005 Nov; 272(22):5799-807. PubMed ID: 16279944
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using
Zarei O; Hamzeh-Mivehroud M; Benvenuti S; Ustun-Alkan F; Dastmalchi S
Adv Pharm Bull; 2017 Apr; 7(1):141-150. PubMed ID: 28507948
[No Abstract] [Full Text] [Related]
17. Macrophage stimulating protein (MSP) binds to its receptor via the MSP beta chain.
Wang MH; Julian FM; Breathnach R; Godowski PJ; Takehara T; Yoshikawa W; Hagiya M; Leonard EJ
J Biol Chem; 1997 Jul; 272(27):16999-7004. PubMed ID: 9202013
[TBL] [Abstract][Full Text] [Related]
18. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
Wang MH; Yao HP; Zhou YQ
Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
[TBL] [Abstract][Full Text] [Related]
19. Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
Bardelli A; Ponzetto C; Comoglio PM
J Biotechnol; 1994 Sep; 37(2):109-22. PubMed ID: 7765452
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic signaling pathways activated by RON receptor tyrosine kinase.
Danilkovitch-Miagkova A
Curr Cancer Drug Targets; 2003 Feb; 3(1):31-40. PubMed ID: 12570659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]